Tamoxifen compared to best supportive care in advanced hepatocelluar carcinoma: A retrospective matched-cohort study

Conclusions Tamoxifen did not show any OS advantage in Egyptian patients with advanced HCC. Use of this drug is discouraged.
Source: Journal of the Egyptian National Cancer Institute - Category: Cancer & Oncology Source Type: research